Navigating the Complexities of Hypertrophic Cardiomyopathy: Payer Considerations on Strategies for Comprehensive Management

Through a multidisciplinary discussion format, the webcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options such as cardiac myosin inhibitors, and the importance of shared decision making to support individualized, high quality care. Using real world HCM case scenarios, the faculty will explore strategies to optimize benefit design, prior authorization, and access pathways to improve clinical and economic outcomes across health systems. Learners will receive targeted, practical insights that can help payers implement evidence based policies that enhance appropriate, timely treatment for patients with HCM.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.